Przejdź do komentarzy
Przejdź do komentarzy

Public activities coordination tool

Public activities coordination tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Regulatory management option analysis (RMOA).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, restriction.

A summary of the all the substance-specific activities can be found under ‘Details’ for each entry.

2,6-di-tert-butyl-p-cresol

EC / List no: 204-881-4 CAS no: 128-37-0
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Targeted
Status
Follow-up
Decision date
25/10/2016
Decision
Latest update
07/05/2019
More information View
DEv 2
Scope
Targeted
Status
Follow-up
Decision date
25/10/2016
Decision
Latest update
07/05/2019
More information View
DEv 3
Scope
Targeted
Status
Concluded
Decision date
13/11/2012
Decision
Latest update
03/12/2018
More information View
DEv 4
Scope
Targeted
Status
Concluded
Decision date
Decision
Latest update
14/10/2018
More information View
DEv 5
Scope
Testing Proposal
Status
Concluded
Decision date
Decision
Latest update
13/10/2018
More information View
SEv - Substance evaluation (Community Rolling Action Plan (CoRAP))
SEv 1
Evaluating Member State
France
Co-Evaluating Member State
Initial grounds for concern
Potential endocrine disruptor
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Year
2016
Status
Ongoing
Conclusion document
Latest update
22/02/2019
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
France
Status
Under development under SEV
Outcome
Under development under SEV
Follow-up
No suggestion yet
Hazard assessment outcome document
Remarks
Concern
Endocrine disruption
Date of intention
12/11/2014
Date of hazard assessment
Latest update
24/10/2018
More information View
Regulatory Management Option Analysis
RMOA 1
Authority
France
Concern
Carcinogenic
Endocrine disruption
Exposure
Skin sensitiser
Status
Concluded
Outcome
Appropriate to initiate regulatory risk management action
Follow-up
Other legislation
RMOA conclusion document
Remarks
Date of intention
12/11/2014
Date of RMOA conclusion
28/02/2017
Latest update
17/01/2019
More information View

Export search results to:

Categories Display

Oznakowane jako:

(kliknij znak, aby wyszukać właściwą treść)


Route: .live1